Cigna (CI) Beats on Q4 Earnings & Revenues

Cigna Corp.CI is a national health benefits company with a comprehensive portfolio of businesses which includes Employee Healthcare, Disability and Life.

Its organizational efficiency plans as well as expansion of Seniors and Medicare business position it well for long run.

The company has a large international presence, which provides diversification benefits.

Cigna is due to be acquired by Anthem Inc. The merger, however, is wrapped in uncertainty with the DoJ opposing to the merger on grounds that the deal would curb competition in the market.

With respect to earnings surprise, Cigna surpassed estimates in three of the past four quarters with an average earnings miss of 0.29%.

Currently, Cigna has a Zacks Rank #3 (Hold), but that could definitely change following Cigna earnings report which was just released. You can see the complete list of today's Zacks #1 Rank stocks here.

We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: Cigna surpassed the earnings estimate. Our consensus called for earning per share of $1.74, and the company reported earnings of $1.87 per share. Earnings per share were, however, flat year over year.

Revenue: Operating revenues of $9.88 billion also surpassed the Zacks Consensus Estimate of $9.59 billion. Revenues also grew 3.2% year over year.

Cigna Corporation Price and EPS Surprise

Cigna Corporation Price and EPS Surprise | Cigna Corporation Quote

Key Stats to Note:

Premiums of $7.6 billion increased 2.1% year over year, while mail order pharmacy revenues increased 10%

Total Medical Customers totaled 15.2 million as on Dec 31, 2016.

Cigna updated its 2017 earnings guidance. It expects earning per share in the range of $9.00 to $9.50. It expects revenues to grow 2% to 3%. The company expects global medical customer growth within a range of 0.3 million to 0.5 million..

Check back later for our full write up on this CI earnings report later!

Zacks' Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors. Click here for Zacks' private trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cigna Corporation (CI): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics

Earnings Investing Stocks

Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More